These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Characteristics, risk factors and outcomes of adult cancer patients with extensively drug-resistant Pseudomonas aeruginosa infections. Samonis G; Vardakas KZ; Kofteridis DP; Dimopoulou D; Andrianaki AM; Chatzinikolaou I; Katsanevaki E; Maraki S; Falagas ME Infection; 2014 Aug; 42(4):721-8. PubMed ID: 24912861 [TBL] [Abstract][Full Text] [Related]
26. Predictors of Mortality in Abdominal Organ Transplant Recipients with Pseudomonas aeruginosa Infections. Su H; Ye Q; Wan Q; Zhou J Ann Transplant; 2016 Feb; 21():86-93. PubMed ID: 26856368 [TBL] [Abstract][Full Text] [Related]
27. Bacteremia and septic shock after solid-organ transplantation. Candel FJ; Grima E; Matesanz M; Cervera C; Soto G; Almela M; Martínez JA; Navasa M; Cofán F; Ricart MJ; Pérez-Villa F; Moreno A Transplant Proc; 2005 Nov; 37(9):4097-9. PubMed ID: 16386636 [TBL] [Abstract][Full Text] [Related]
28. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study. Deal EN; Micek ST; Reichley RM; Ritchie DJ Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902 [TBL] [Abstract][Full Text] [Related]
29. The Distribution and Resistance of Pathogens Among Solid Organ Transplant Recipients with Pseudomonas aeruginosa Infections. Luo A; Zhong Z; Wan Q; Ye Q Med Sci Monit; 2016 Apr; 22():1124-30. PubMed ID: 27045418 [TBL] [Abstract][Full Text] [Related]
30. A novel combination regimen for the treatment of refractory bacteremia due to multidrug-resistant Pseudomonas aeruginosa in a liver transplant recipient. Sun HY; Shields RK; Cacciarelli TV; Muder RR; Singh N Transpl Infect Dis; 2010 Dec; 12(6):555-60. PubMed ID: 20626709 [TBL] [Abstract][Full Text] [Related]
31. Antibiotic pressure is a major risk factor for rectal colonization by multidrug-resistant Pseudomonas aeruginosa in critically ill patients. Gómez-Zorrilla S; Camoez M; Tubau F; Periche E; Cañizares R; Dominguez MA; Ariza J; Peña C Antimicrob Agents Chemother; 2014 Oct; 58(10):5863-70. PubMed ID: 25049255 [TBL] [Abstract][Full Text] [Related]
32. Outcomes of bacteremia due to Pseudomonas aeruginosa with reduced susceptibility to piperacillin-tazobactam: implications on the appropriateness of the resistance breakpoint. Tam VH; Gamez EA; Weston JS; Gerard LN; Larocco MT; Caeiro JP; Gentry LO; Garey KW Clin Infect Dis; 2008 Mar; 46(6):862-7. PubMed ID: 18279040 [TBL] [Abstract][Full Text] [Related]
33. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. Tumbarello M; Repetto E; Trecarichi EM; Bernardini C; De Pascale G; Parisini A; Rossi M; Molinari MP; Spanu T; Viscoli C; Cauda R; Bassetti M Epidemiol Infect; 2011 Nov; 139(11):1740-9. PubMed ID: 21226988 [TBL] [Abstract][Full Text] [Related]
34. Bacteremia in transplant recipients: a prospective study of demographics, etiologic agents, risk factors, and outcomes. Wagener MM; Yu VL Am J Infect Control; 1992 Oct; 20(5):239-47. PubMed ID: 1443756 [TBL] [Abstract][Full Text] [Related]
35. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved? Bhat S; Fujitani S; Potoski BA; Capitano B; Linden PK; Shutt K; Paterson DL Int J Antimicrob Agents; 2007 Nov; 30(5):458-62. PubMed ID: 17703923 [TBL] [Abstract][Full Text] [Related]
36. Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa. Yakupogullari Y; Otlu B; Dogukan M; Gursoy C; Korkmaz E; Kizirgil A; Ozden M; Durmaz R Am J Infect Control; 2008 Dec; 36(10):e13-8. PubMed ID: 19084158 [TBL] [Abstract][Full Text] [Related]
37. Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients. Oliveira AL; de Souza M; Carvalho-Dias VM; Ruiz MA; Silla L; Tanaka PY; Simões BP; Trabasso P; Seber A; Lotfi CJ; Zanichelli MA; Araujo VR; Godoy C; Maiolino A; Urakawa P; Cunha CA; de Souza CA; Pasquini R; Nucci M Bone Marrow Transplant; 2007 Jun; 39(12):775-81. PubMed ID: 17438585 [TBL] [Abstract][Full Text] [Related]
38. Nosocomial spread of class 1 integron-carrying extensively drug-resistant Pseudomonas aeruginosa isolates in a Thai hospital. Kiddee A; Henghiranyawong K; Yimsabai J; Tiloklurs M; Niumsup PR Int J Antimicrob Agents; 2013 Oct; 42(4):301-6. PubMed ID: 23845503 [TBL] [Abstract][Full Text] [Related]
39. Previous ciprofloxacin exposure is associated with resistance to beta-lactam antibiotics in subsequent Pseudomonas aeruginosa bacteremic isolates. López-Dupla M; Martínez JA; Vidal F; Almela M; Soriano A; Marco F; López J; Olona M; Mensa J Am J Infect Control; 2009 Nov; 37(9):753-8. PubMed ID: 19487049 [TBL] [Abstract][Full Text] [Related]
40. Risk factors, clinical features, and outcome of Pseudomonas aeruginosa bacteremia in patients with hematologic malignancies: a case-control study. Vuotto F; Berthon C; Lemaitre N; Duhamel A; Balkaran S; Le Ray E; Micol JB; Faure K; Alfandari S Am J Infect Control; 2013 Jun; 41(6):527-30. PubMed ID: 23219670 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]